Phototherapy Device Market to Grow as Demand Rises for Neonatal Care and Skin Disease Treatment

Market Estimation, Growth Drivers and Opportunities

The global Phototherapy Device Market was valued at USD 649.37 million in 2025 and is projected to reach nearly USD 860.30 million by 2032, registering a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032. Market growth is supported by the increasing prevalence of skin conditions, including psoriasis, eczema and vitiligo, alongside the need to treat neonatal jaundice. Phototherapy uses controlled light exposure to manage selected medical conditions and is applied in hospitals, specialty clinics and home-care settings.

The rising number of premature and low-birth-weight infants creates demand for neonatal phototherapy, while growing awareness of non-invasive treatment options supports adoption in dermatology. Improvements in light-emitting diode (LED) technology, treatment efficiency, device portability and ease of operation are creating opportunities for manufacturers. Home-based phototherapy may also improve convenience for suitable patients by reducing repeated clinic visits. However, equipment costs, regulatory requirements, limited awareness and concerns about potential treatment-related side effects remain challenges for market participants.

* Connect with Our Market Experts: https://www.maximizemarketresearch.com/request-sample/121745/ 

U.S. Market Trends and Investment

The United States remains an important market for phototherapy devices because of its established healthcare infrastructure, specialist dermatology services and neonatal care capabilities. In 2025, product development continued to highlight opportunities for more convenient neonatal treatment: the U.S. Food and Drug Administration received a 510(k) submission for Thera B Medical Products’ SnugLit wearable phototherapy system in April 2025. The FDA subsequently issued a substantial-equivalence decision in January 2026, so that decision should not be described as a completed 2025 approval. The development illustrates the industry's interest in wearable approaches to neonatal jaundice management. Continued investment in clinical validation, compact LED systems and devices designed to support care outside traditional hospital settings could expand access, subject to regulatory clearance and clinical suitability.

Market Segmentation: Largest-Share Segments

By end user, hospitals and specialty clinics held the largest share of the market, with revenue assessed at USD 378.0 million in 2025. These facilities benefit from trained healthcare professionals, established treatment protocols and access to equipment for neonatal and dermatological care. Hospitals are particularly important when patients require clinical monitoring or treatment decisions by specialists.

The market is segmented by technology into conventional, LED-based and fiber-optic phototherapy devices. By application, it covers skin disease treatment—including psoriasis, vitiligo and eczema—and neonatal jaundice management. By end user, it includes hospitals and specialty clinics as well as home users. The available market data identifies hospitals and specialty clinics as the largest end-user segment; it does not provide sufficient evidence to assign an unsupported leading-share claim to every other category.

Phototherapy Device Market, Key Players
1. GE Healthcare
2. Atom Medical
3. Draeger
4. Herbert Waldmann
5. Natus Medical
6. Daavlin
7. Beurer
8. National Biological
9. David
10.Solarc Systems Inc.
11.UVBioTek
12.MTTS Asia
13.Nice Neotech
14.Signify Holding
15.Phoenix Medical Corporation
16.Strata Skin Sciences
17.National Biological Corporation
18.Hill-Rom
19.Medisana AG
20.Schulze & Böhm GmbH

Competitive Analysis: Key Companies

The competitive landscape includes GE HealthCare, ATOM MEDICAL, Dräger, Herbert Waldmann and Natus Medical, all identified among the market's key players. The market report does not publish verifiable individual market-share percentages for these companies, so they should not be interpreted as a confirmed ranking by share.

GE HealthCare participates in neonatal care equipment, where reliability, integration with hospital workflows and support for clinical teams are important competitive factors. ATOM MEDICAL focuses on neonatal and infant-care technologies, making newborn treatment an important area of relevance. Dräger supplies neonatal-care equipment and competes through clinical functionality, safety and integration with intensive-care environments. Herbert Waldmann brings expertise in medical lighting and phototherapy systems, with light delivery and treatment usability central to product development. Natus Medical operates in newborn-care and medical technology markets, where solutions that support diagnosis and treatment can strengthen its position.

Across the industry, product-development opportunities include energy-efficient LEDs, improved light distribution, portable systems, wearable neonatal solutions and easier-to-use controls. Investment in clinical evidence, regulatory compliance, after-sales support and training can help manufacturers differentiate their products. Specific recent investments or policy changes should be attributed only where companies have publicly confirmed them; unsupported company-specific investment claims are not included here.

Regional Analysis

United States: Demand is supported by advanced hospitals, established dermatology services and ongoing innovation in neonatal-care devices. FDA oversight shapes product development and market entry, making regulatory compliance a key consideration for manufacturers.

United Kingdom: The UK benefits from established healthcare services and specialist treatment pathways for dermatological conditions and newborn care. Adoption opportunities depend on clinical need, procurement decisions and evidence that devices provide safe and effective treatment.

Germany: Germany's developed healthcare system and medical-technology sector support demand for hospital-based equipment. Product reliability, compliance with applicable European medical-device requirements and the ability to serve specialist clinical needs influence purchasing decisions.

France: Demand is linked to hospital and dermatology services, neonatal care and access to treatment for chronic skin conditions. Healthcare procurement and clinical assessment play important roles in device adoption.

Japan: An advanced healthcare system and emphasis on neonatal and specialist medical care create opportunities for reliable, technically advanced phototherapy equipment. Compact designs and efficient operation may appeal to hospitals facing space and workflow constraints.

China: Healthcare infrastructure development and wider access to medical services create potential for phototherapy-device adoption. Investment in hospitals and neonatal care, alongside demand for dermatology services, may support growth. The market report projects China's phototherapy-device market to reach approximately USD 216.4 million by 2030, with a reported CAGR of 5.1% from 2025 to 2032.

Related Reports: 

Pupillometer Market https://www.maximizemarketresearch.com/market-report/pupillometer-market/213391/ 

Gene Expression Market https://www.maximizemarketresearch.com/market-report/gene-expression-market/215470/ 

Metaverse in Healthcare Market https://www.maximizemarketresearch.com/market-report/metaverse-in-healthcare-market/213965/ 

Conclusion

The phototherapy device market is positioned for steady expansion as healthcare providers address neonatal jaundice and chronic skin conditions. Hospitals and specialty clinics remain the largest end-user segment, while advances in LED technology and portable or wearable designs present further opportunities. Manufacturers that combine clinical evidence, safety, regulatory compliance and accessible device designs will be better positioned to compete. Expanding suitable home-care options and improving access to phototherapy in developing healthcare systems could provide additional growth, provided that treatment remains guided by qualified healthcare professionals.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 sales@maximizemarketresearch.com